Skip to main content

Levonorgestrel

NDC 40032-622 · Novel Laboratories, Inc.

Generic nameLevonorgestrel
Dosage formTABLET
RouteORAL
Active ingredient(s)LEVONORGESTREL
Strength1.5 mg/1
Pharmacologic classInhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]
Marketing categoryANDA

Packages

40032-622-30 — 1 TABLET in 1 CARTON (40032-622-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0023-5858 — Levonorgestrel, 0113-2003 — levonorgestrel, 0113-8099 — levonorgestrel, 0480-3472 — Levonorgestrel and Ethinyl Estradiol, 0536-1433 — Levonorgestrel, 16714-809 — levonorgestrel, 43386-622 — Levonorgestrel, 50090-5978 — levonorgestrel, 50102-211 — Levonorgestrel, 50419-422 — Levonorgestrel, 50419-423 — Levonorgestrel, 50419-424 — Levonorgestrel, 50419-491 — Estradiol and Levonorgestrel, 50742-352 — levonorgestrel, 50742-659 — Levonorgestrel and Ethinyl Estradiol, 51660-096 — levonorgestrel, 51660-723 — Levonorgestrel, 51660-999 — Levonorgestrel, 58602-712 — Levonorgestrel, 58602-721 — Levonorgestrel, +46 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels